129 related articles for article (PubMed ID: 35482566)
1. ATP7A, ATP7B, and RETN genotypes in Labrador Retrievers with and without copper-associated hepatopathy.
Langlois DK; Nagler BSM; Smedley RC; Yang YT; Yuzbasiyan-Gurkan V
J Am Vet Med Assoc; 2022 Apr; 260(14):1-8. PubMed ID: 35482566
[TBL] [Abstract][Full Text] [Related]
2. Association of the canine ATP7A and ATP7B with hepatic copper accumulation in Dobermann dogs.
Wu X; Mandigers PJJ; Watson AL; van den Ingh TSGAM; Leegwater PAJ; Fieten H
J Vet Intern Med; 2019 Jul; 33(4):1646-1652. PubMed ID: 31254371
[TBL] [Abstract][Full Text] [Related]
3. The Menkes and Wilson disease genes counteract in copper toxicosis in Labrador retrievers: a new canine model for copper-metabolism disorders.
Fieten H; Gill Y; Martin AJ; Concilli M; Dirksen K; van Steenbeek FG; Spee B; van den Ingh TS; Martens EC; Festa P; Chesi G; van de Sluis B; Houwen RH; Watson AL; Aulchenko YS; Hodgkinson VL; Zhu S; Petris MJ; Polishchuk RS; Leegwater PA; Rothuizen J
Dis Model Mech; 2016 Jan; 9(1):25-38. PubMed ID: 26747866
[TBL] [Abstract][Full Text] [Related]
4. Predicting copper toxicosis: relationship between the ATP7A and ATP7B gene mutations and hepatic copper quantification in dogs.
Pindar S; Ramirez C
Hum Genet; 2019 May; 138(5):541-546. PubMed ID: 31062085
[TBL] [Abstract][Full Text] [Related]
5. Genotype frequency of ATP7A and ATP7B mutation-related copper-associated hepatitis in a Japanese guide dog Labrador retriever population.
Takanosu M; Suzuki K
J Vet Med Sci; 2022 Jan; 84(1):16-19. PubMed ID: 34819411
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of COMMD1 in copper toxicosis in Labrador retrievers and Dobermans.
Wu X; Mandigers PJJ; Fieten H; Leegwater PA
Vet J; 2020 Nov; 265():105561. PubMed ID: 33129558
[TBL] [Abstract][Full Text] [Related]
7. Investigation of Genetic Modifiers of Copper Toxicosis in Labrador Retrievers.
Wu X; den Boer ER; Vos-Loohuis M; Steenbeek FGV; Monroe GR; Nijman IJ; Leegwater PAJ; Fieten H
Life (Basel); 2020 Oct; 10(11):. PubMed ID: 33142854
[TBL] [Abstract][Full Text] [Related]
8. Acquired proximal renal tubular dysfunction in 9 Labrador Retrievers with copper-associated hepatitis (2006-2012).
Langlois DK; Smedley RC; Schall WD; Kruger JM
J Vet Intern Med; 2013; 27(3):491-9. PubMed ID: 23527903
[TBL] [Abstract][Full Text] [Related]
9. Canine Copper-Associated Hepatitis.
Dirksen K; Fieten H
Vet Clin North Am Small Anim Pract; 2017 May; 47(3):631-644. PubMed ID: 28063745
[TBL] [Abstract][Full Text] [Related]
10. Dietary management of labrador retrievers with subclinical hepatic copper accumulation.
Fieten H; Biourge VC; Watson AL; Leegwater PA; van den Ingh TS; Rothuizen J
J Vet Intern Med; 2015; 29(3):822-7. PubMed ID: 25776942
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and Specificity of Plasma ALT, ALP, and Bile Acids for Hepatitis in Labrador Retrievers.
Dirksen K; Burgener IA; Rothuizen J; van den Ingh TSGAM; Penning LC; Spee B; Fieten H
J Vet Intern Med; 2017 Jul; 31(4):1017-1027. PubMed ID: 28543991
[TBL] [Abstract][Full Text] [Related]
12. Hepatic copper concentrations in 546 dogs (1982-2015).
Strickland JM; Buchweitz JP; Smedley RC; Olstad KJ; Schultz RS; Oliver NB; Langlois DK
J Vet Intern Med; 2018 Nov; 32(6):1943-1950. PubMed ID: 30294943
[TBL] [Abstract][Full Text] [Related]
13. Hepatic copper concentrations in Labrador Retrievers with and without chronic hepatitis: 72 cases (1980-2010).
Johnston AN; Center SA; McDonough SP; Wakshlag JJ; Warner KL
J Am Vet Med Assoc; 2013 Feb; 242(3):372-80. PubMed ID: 23327181
[TBL] [Abstract][Full Text] [Related]
14. Demographic and histopathologic features of dogs with abnormally high concentrations of hepatic copper.
Ullal TV; Lakin S; Gallagher B; Sbardellati N; Abdo Z; Twedt DC
J Vet Intern Med; 2022 Nov; 36(6):2016-2027. PubMed ID: 36318874
[TBL] [Abstract][Full Text] [Related]
15. Canine copper-associated hepatitis: A retrospective study of 17 clinical cases.
Rodrigues A; Leal RO; Girod M; Dally C; Guery E; Gomes E; Hernandez J
Open Vet J; 2020 Aug; 10(2):128-134. PubMed ID: 32821657
[TBL] [Abstract][Full Text] [Related]
16. Chronic hepatitis in Labrador Retrievers: clinical presentation and prognostic factors.
Shih JL; Keating JH; Freeman LM; Webster CR
J Vet Intern Med; 2007; 21(1):33-9. PubMed ID: 17338147
[TBL] [Abstract][Full Text] [Related]
17. Ammonium tetrathiomolybdate treatment of copper-associated hepatopathy in dogs.
Langlois DK; Querubin JR; Schall WD; Nelson NC; Smedley RC
J Vet Intern Med; 2019 May; 33(3):1336-1343. PubMed ID: 30883912
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte-derived microRNAs as sensitive serum biomarkers of hepatocellular injury in Labrador retrievers.
Dirksen K; Verzijl T; van den Ingh TS; Vernooij JC; van der Laan LJ; Burgener IA; Spee B; Fieten H
Vet J; 2016 May; 211():75-81. PubMed ID: 27021912
[TBL] [Abstract][Full Text] [Related]
19. Peripheral markers of oxidative stress in Labrador retrievers with copper-associated hepatitis.
Vincent AM; Sordillo LM; Smedley RC; Gandy JC; Brown JL; Langlois DK
J Small Anim Pract; 2021 Oct; 62(10):866-873. PubMed ID: 34029383
[TBL] [Abstract][Full Text] [Related]
20. Copper-associated hepatitis in Labrador Retrievers.
Smedley R; Mullaney T; Rumbeiha W
Vet Pathol; 2009 May; 46(3):484-90. PubMed ID: 19176511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
